These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2626353)
1. [Usefulness of determining hepatic clearance of Tc-HEPIDA in the diagnosis and differential diagnosis of chronic diseases of the liver parenchyma]. Kuydowicz J; Studniarek M; Wojciechowski A; Liniecki J Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):358-60. PubMed ID: 2626353 [No Abstract] [Full Text] [Related]
2. Comparison of (99m)Tc-HEPIDA and (99m)Tc-MBrIDA from the standpoint of hepatic clearance determination-- preliminary communication. Surma MJ; Deroń Z; Frieske I; Pietrzak-Stelmasiak E; Kuśmierek J Nucl Med Rev Cent East Eur; 2009; 12(2):72-7. PubMed ID: 20235057 [TBL] [Abstract][Full Text] [Related]
3. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance. Surma MJ; Frieske I; Jencz K; Kuźmierek J Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475 [TBL] [Abstract][Full Text] [Related]
4. [Diurnal variability of hepatic clearance of antipyrine and Tc-99m-HIDA in healthy persons and in those with liver diseases. I]. Hartleb M; Markiewicz A; Rudzki K; Nowak S; Bołdys H; Kacperek T Pol Arch Med Wewn; 1987 Jun; 77(6):264-9. PubMed ID: 3271278 [No Abstract] [Full Text] [Related]
5. 99mTc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of plasma and hepatic clearance for assessment of hepatic parenchyma performance. Frieske I; Surma MJ; Bieńkiewicz M; Białkowska-Warzecha J; Liniecki J; Kuydowicz J; Kuśmierek J Nucl Med Rev Cent East Eur; 2003; 6(1):23-8. PubMed ID: 14600929 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of the diagnostic usefulness of Tc-HEPIDA and Tc 99m p-butyl-IDA complexes]. Studniarek M; Liniecki J; Kapuściński J; Durski K; Brykalski D Pol Przegl Radiol; 1987; 51(5):245-9. PubMed ID: 3333177 [No Abstract] [Full Text] [Related]
7. [Clinical variability of hepatic clearance of antipyrine and Tc-99m-HIDA in healthy persons and in those with liver diseases. II. Effect of propranolol]. Hartleb M; Markiewicz A; Rudzki K; Nowak S; Bołdys H; Kacperek T Pol Arch Med Wewn; 1987 Jun; 77(6):270-5. PubMed ID: 3271279 [No Abstract] [Full Text] [Related]
8. Comments on radionuclide hepatic scanning. Rothschild MA; Oratz M; Schreiber SS Semin Liver Dis; 1982 Feb; 2(1):29-40. PubMed ID: 7051317 [No Abstract] [Full Text] [Related]
9. Uncertainty analysis of (99m)Tc-HEPIDA liver clearance determination. Surma MJ Nucl Med Rev Cent East Eur; 2005; 8(2):116-24. PubMed ID: 16437397 [TBL] [Abstract][Full Text] [Related]
10. A dichotomy in hepatic uptake of 99mTc-IDA and 99mTc-colloid. Lamki L Semin Nucl Med; 1982 Jan; 12(1):92-4. PubMed ID: 7079773 [No Abstract] [Full Text] [Related]
11. 99mTc colloid and 99mTc IDA imagings in diffuse hepatic disease. Aburano T; Yokoyama K; Shuke N; Takayama T; Michigishi T; Tonami N; Hisada K; Unoura M; Kobayashi K J Clin Gastroenterol; 1993 Dec; 17(4):321-6. PubMed ID: 8308221 [TBL] [Abstract][Full Text] [Related]
12. [Radioisotope diagnosis of the changes in the hepatobiliary tract in children]. Zubovskiĭ GA; Zaprudnov AM Sov Med; 1990; (7):87-90. PubMed ID: 2251574 [No Abstract] [Full Text] [Related]
13. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function]. Custro N; De Francisci MC; Patanella I; Scafidi V; Indovina I Minerva Med; 1984 Nov; 75(42):2527-32. PubMed ID: 6083507 [TBL] [Abstract][Full Text] [Related]
14. Specific 99mTC-HEPIDA hepatic clearance--essential value ranges from a clinical stand-point. Frieske I; Surma MJ; Bieńkiewicz M; Kuśmierek J Nucl Med Rev Cent East Eur; 2006; 9(1):56-9. PubMed ID: 16791806 [TBL] [Abstract][Full Text] [Related]